Functional dyspepsia: Evaluation and treatment

Gastroenterology Clinics of North America

Volumn 32, Issue 2, 2003, Pages 577-599

  Simrén, Magnus ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMCINAL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CISAPRIDE; CITALOPRAM; CLONIDINE; DOMPERIDONE; ERYTHROMYCIN; FEDOTOZINE; HISTAMINE H2 RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR AGONIST; METOCLOPRAMIDE; MIANSERIN; NITRIC OXIDE DONOR; OMEPRAZOLE; PAROXETINE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SEROTONIN 1 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; SUMATRIPTAN; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACID SECRETION; AUTONOMIC NERVOUS SYSTEM; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DUODENUM MOTILITY; DYSPEPSIA; FUNCTIONAL DYSPEPSIA; GENERAL PRACTICE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MENTAL DISEASE; META ANALYSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PEPTIC ULCER; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; STOMACH EMPTYING; STOMACH FUNCTION; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0038387791     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00023-2     Document Type: Review

References (135)

1. Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-80.
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
3. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5.
4. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993;38:147-54.
5. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45(suppl 2):II37-42.
6. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJD. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-68.
7. Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347-55.
8. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83-9.
9. Björnsson ES, Abrahamsson H. Contractile patterns in patients with severe chronic dyspepsia. Am J Gastroenterol 1999;94:54-64.
10. Feinle C, Meier O, Otto B, D'Amato M, Fried M. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001;48:347-55.
11. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996;41:689-96.
12. Haug TT, Svebak S, Wilhelmsen I, Berstad A, Ursin H. Psychological factors and somatic symptoms in functional dyspepsia: a comparison with duodenal ulcer and healthy controls. J Psychosom Res 1994;38:281-91.
13. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999;116:515-20.
14. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
15. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-52.
16. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001;121:526-35.
17. Tucci A, Corinaldesi R, Stanghellini V, Tosetti C, Di Febo G, Paparo GF, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992;103:768-74.
18. Wilmer A, Van Cutsem E, Andrioli A, Tack J, Coremans G, Janssens J. Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut 1998;42:235-42.
19. Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, et al. Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999;94:2080-5.
20. Maes BD, Ghoos YF, Hiele MI, Rutgeerts PJ. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997;42:1158-62.
21. Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJ, Hoes AW. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998;43:2028-33.
22. Azpiroz F, Malagelada JR. Intestinal control of gastric tone. Am J Physiol 1985; 249:G501-9.
23. Jahnberg T, Abrahamsson H, Jansson G, Martinson J. Gastric relaxatory response to feeding before and after vagotomy. Scand J Gastroenterol 1977;12:225-8.
24. Azpiroz F, Malagelada JR. Importance of vagal input in maintaining gastric tone in the dog. J Physiol 1987;384:511-24.
25. Coulie B, Tack J, Sifrim D, Andrioli A, Janssens J. Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999;276:G373-7.
26. Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 1991;351:477-9.
27. Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994;35:327-32.
28. Salet GA, Samsom M, Roelofs JM, van Berge Henegouwen GP, Smout AJ, Akkermans LM. Responses to gastric distension in functional dyspepsia. Gut 1998; 42:823-9.
29. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999;44:55-64.
30. Kim DY, Delgado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK, et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001;96:3099-105.
31. Boeckxstaens GE, Hirsch DP, Kuiken SD, Heisterkamp SH, Tytgat GN. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002;97:40-8.
32. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001;48:125-31.
33. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-93.
34. Bradette M, Pare P, Douville P, Morin A. Visceral perception in health and functional dyspepsia: crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 1991;36:52-8.
35. Coffin B, Azpiroz F, Guarner F, Malagelada JR. Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994;107: 1345-51.
36. Holtmann G, Gcebell H, Talley J. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 1996;91:485-91.
37. Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia: the irritable stomach syndrome. Dig Dis Sci 1991;36:1249-54.
38. Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998;42:814-22.
39. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut 2000;47:332-6.
40. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991;101:999-1006.
41. Holtmann G, Talley NJ, Goebell H. Association between H pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 1996;41:1285-91.
42. Mearin F, de Ribot X, Balboa A, Salas A, Varas MJ, Cucala M, et al. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995;37:47-51.
43. Houghton LA, Mangall YF, Dwivedi A, Read NW. Sensitivity to nutrients in patients with non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 1993;5:109-13.
44. Barbera R, Feinle C, Read NW. Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995;40:1636-41.
45. Barbera R, Feinle C, Read NW. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995;7:1051-7.
46. Feinle C, Read NW. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am J Physiol 1996;271:G591-7.
47. Simrén M, Abrahamsson H, Björnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001;48:20-7.
48. Simrén M, Simms L, D'Souza D, Abrahamsson H, Björnsson E. Lipid-induced colonic hypersensitivity in irritable bowel syndrome (IBS): the role of 5-HT3 receptors. Neurogastroenterol Motil 2001;13:431.
49. Collen MJ, Loebenberg MJ. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 1989;34:246-50.
50. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991;101: 3-6.
51. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-65.
52. Schwartz MP, Samsom M, Smout AJ. Chemospecific alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001;96:2596-602.
53. Schwartz MP, Samsom M, Van Berge Henegouwen GP, Smout AJ. Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Aliment Pharmacol Ther 2001;15:1921-8.
54. Lee KJ, Demarchi B, Vos R, Demedts I, Janssens J, Tack J. Comparison of duodenal acid exposure in functional dyspepsia patients and healthy controls using 24-hour ambulatory duodenal pH monitoring. Gastroenterology 2002;122:A-102.
55. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991;100:1311-8.
56. Stanghellini V, Ghidini C, Maccarini MR, Paparo GF, Corinaldesi R, Barbara L. Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut 1992;33:184-90.
57. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998;115:747-62.
58. Jebbink HJ, vanBerge-Henegouwen GP, Akkermans LM, Smout AJ. Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry. Gut 1996;38:694-700.
59. Simrén M, Castedal M, Svedlund J, Abrahamsson H, Björnsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Dig Dis Sci 2000;45:2151-61.
60. Azpiroz F, Malagelada JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987;92:934-43.
61. Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995;109:755-65.
62. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994;35:536-41.
63. Tack J, Vos R, Caenepeel P, Degreef T, Piessevaux H, Janssens J. Fundic tension receptors mediate perception in functional dyspepsia patients with hypersensitivity to gastric distensions. Gastroenterology 2001;120:A-1244.
64. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
65. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000;160:1192-8.
66. Hausken T, Svebak S, Wilhelmsen I, Haug TT, Olafsen K, Pettersson E, et al. Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med 1993;55:12-22.
67. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 1998;42:501-6.
68. de Silva LO, Souza A, Mesquita MA. Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability. Dig Dis Sci 2002;47: 27-31.
69. Troncon LE, Thompson DG, Ahluwalia NK, Barlow J, Heggie L. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut 1995;37:17-22.
70. Bennett EJ, Kellow JE, Cowan H, Scott AM, Shuter B, Langeluddecke PM, et al. Suppression of anger and gastric emptying in patients with functional dyspepsia. Scand J Gastroenterol 1992;27:869-74.
71. Haug TT, Svebak S, Hausken T, Wilhelmsen I, Berstad A, Ursin H. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994;56:181-6.
72. Wilhelmsen I, Haug TT, Ursin H, Berstad A. Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer: significance of somatization. Dig Dis Sci 1995;40:1105-11.
73. Fischler B, Vandenberghe J, Persoons P, De Gucht V, Broekaert D, Luyckx K, et al. Evidence-based subtypes in functional dyspepsia with confirmatory factor analysis: psychosocial and physiopathological correlates. Gastroenterology 2001;120:268.
74. Tack J, Caenepeel P, Degreef A, Janssens J. Symptom severity and subtypes in functional dyspepsia: Rome II criteria or a pathophysiological approach? Gastroenterology 2000;118:A619.
75. Tack J, Caenepeel P, Vos R, Janssens J. A satiety test to assess gastric accommodation in functional dyspepsia. Gastroenterology 2002;118:2046.
76. Boeckxstaens GE, Hirsch DP, Van Den Elzen BD, Heisterkamp SH, Tytgat GN. Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology 2001;121:1054-63.
77. Cuomo R, Sarnelli G, Grasso R, Bruzzese D, Pumpo R, Salomone M, et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol 2001;36:1030-6.
78. Strid H, Norström M, Sjöberg J, Simren M, Svedlund J, Abrahamsson H, et al. Impact of sex and psychological factors on the water loading test in functional dyspepsia. Scand J Gastroenterol 2001;36:725-30.
79. Collins SM. Irritable bowel syndrome could be an inflammatory disorder. Eur J Gastroenterol Hepatol 1994;6:478-82.
80. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea [see comments]. Lancet 1996;347:150-3.
81. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis-clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92:1501-4.
82. Tack J, Demedts I, Dehondt G, Caenepeel P, Fischler B, Zandecki M, et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002;122:1738-47.
83. Agreus L. Natural history of dyspepsia. Gut 2002;50(suppl 4):2-9.
84. Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002; 50(suppl 4):17-20.
85. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002;50(suppl 4): 72-8.
86. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9.
87. Tack J, Lee K, Sifrim D, Janssens J. Prevalence and symptomatic impact of non-erosive reflux disease in functional dyspepsia. Gastroenterology 2002;122:786.
88. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001;96:2905-14.
89. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001;96:1340-9.
90. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
91. Goves J, Oldring JK, Kerr D, Dallara RG, Roffe EJ, Powell JA, et al. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther 1998;12:147-57.
92. Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Aliment Pharmacol Ther 1997;11:541-6.
93. Mason I, Millar LJ, Sheikh RR, Evans WM, Todd PL, Turbitt ML, et al. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group. Aliment Pharmacol Ther 1998; 12:263-71.
94. American Gastroenterological Association medical position statement. evaluation of dyspepsia. Gastroenterology 1998;114:579-81.
95. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998;114:582-95.
96. Spiegel BM, Vakil NB, Ofman JJ. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 2002;122:1270-85.
97. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995;122:107-12.
98. Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001;15:1291-9.
99. Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen SA, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis: a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999;13:907-14.
100. Corinaldesi R, Stanghellini V, Raiti C, Rea E, Salgemini R, Barbara L. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987;28:300-5.
101. Tack J, Broeckaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998;12:761-6.
102. Kellow JE, Cowan H, Shuter B, Riley JW, Lunzer MR, Eckstein RP, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995;9:153-60.
103. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001;96:689-96.
104. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-74.
105. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group [see comments]. N Engl J Med 1998;339:1875-81.
106. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999;318:833-7.
107. Talley NJ, Vakil N, Ballard ED III, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341: 1106-11.
108. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994;39:2352-63.
109. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5.
110. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder: a double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996;31:318-25.
111. Tack J, Schnackers D, Coulie B, et al. 5-hydroxytryptamine is involved in the gastric accommodation reflex in man. Neurogastroenterol Motil 1998;10:475.
112. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999;116:573-85.
113. Tack J, Vos R, Janssens J, Salter J, Jauffret S, Vandeplassche G. Influence of tegaserod on proximal gastric sensory and motor function in man. Gastroenterology 2002; 122:T1308.
114. Degen L, Matzinger D, Merz M, Appel-Dingemanse S, Osborne S, Luchinger S, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001;15: 1745-51.
115. Tack J, Delia T, Ligozio G, Sus S, Lefkowitz M, Vandeplassche G. A phase II placebo controlled randomized trial with tegaserod (T) in functional dyspepsia (FD) patients with normal gastric emptying (NGE). Gastroenterology 2002;122:154.
116. Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46:468-73.
117. Sarnelli G, Janssens J, Tack J. Effect of intranasal sumatriptan on gastric tone and sensitivity to distension. Dig Dis Sci 2001;46:1591-5.
118. Tack J, Piessevaux H, Coulie B, Fischler B, De Gucht V, Janssens J. A placebo-controlled trial of buspirone, a fundus-relaxing drug in functional dyspepsia: effect on symptoms and gastric sensory and motor function. Gastroenterology 1999;116:G1423.
119. Sarnelli G, Vos R, Sifrim D, Janssens J, Tack J. Influence of sildenafil on fasting and postprandial gastric tone in man. Gastroenterology 2001;120:1478.
120. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001;15:525-37.
121. Zerbib F, Bruley des Varannes S, Oriola RC, McDonald J, Isal JP, Galmiche JP. Alosetron does not affect the visceral perception of gastric distension in healthy subjects. Aliment Pharmacol Ther 1994;8:403-7.
122. Thompson CA. Alosetron withdrawn from market. Am J Health Syst Pharm 2001;58:13.
123. Coffin B, Bouhassira D, Chollet R, Fraitag B, De Meynard C, Geneve J, et al. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996;10:919-25.
124. Read NW, Abitbol JL, Bardhan KD, Whorwell PJ, Fraitag B. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997;41:664-8.
125. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med 1990;322:1028-31.
126. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000;14:1653-61.
127. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: A randomised, double blind, placebo controlled trial. Gut 2001; 49:395-401.
128. Tack J, Peeters T. What comes after macrolides and other motilin stimulants? Gut 2001;49:317-8.
129. Bruley des Varannes S, Parys V, Ropert A, Chayvialle JA, Roze C, Galmiche JP. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. Gastroenterology 1995;109:32-9.
130. Piessevaux H, Tack J, Wilmer A, Coulie B, Geubel A, Janssens J. Perception of changes in wall tension of the proximal stomach in humans. Gut 2001;49:203-8.
131. Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414-20.
132. Haug TT, Wilhelmsen I, Svebak S, Berstad A, Ursin H. Psychotherapy in functional dyspepsia. J Psychosom Res 1994;38:735-44.
133. Hamilton J, Guthrie E, Creed F, Thompson D, Tomenson B, Bennett R, et al. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000;119:661-9.
134. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002;97:954-61.
135. Calvert EL, Houghton LA, Cooper P, Whorwell P. Hypnotherapy is effective in the long-term treatment of functional dyspepsia. Gastroenterology 2001;120:618.